U.S. Food and Drug Administration (FDA)
Is KPV legal in United States?
Not approvedNo FDA approval; FDA found no human exposure data for KPV, and an advisory panel recommended considering it in July 2026 (non-binding)
Not approved as a medicine here.
KPV is not approved for any use. FDA's Category 2 page lists it among withdrawn nominations and says FDA identified no human exposure data for KPV drug products by any route. The Pharmacy Compounding Advisory Committee reviewed KPV for wound healing and inflammatory conditions on 23 July 2026 and, per a law-firm report, voted 8 to 6 with one abstention to recommend it for the 503A bulks list. That vote is advisory, so KPV is not currently on the list.
Last verified 2026-09-29 · how we verify
KPV elsewhere
Sources (4)
- 01Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Category 2 and withdrawn nominations)U.S. Food and Drug Administration · 2026-04-22 · accessed 2026-09-29
- 02July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory CommitteeU.S. Food and Drug Administration · 2026-08-06 · accessed 2026-09-29
- 03Bulk list bound? PCAC backs majority of peptides in two-day public meetingMcDermott Will & Schulte · 2026-07-27 · accessed 2026-09-29
- 04FDA's Advisory Committee Votes on Peptides: What It Does and Does Not MeanMintz · 2026-07-29 · accessed 2026-09-29